Skip to main content
. 2022 Oct 9;12(16):7108–7131. doi: 10.7150/thno.74820

Figure 3.

Figure 3

Binding site barrier of TSPC in a tumor. The preferential accumulation of high-affinity ligands/antibodies in the immediate proximity of blood vessels might hinder the deep penetration of TSPCs into the tumor parenchyma.